3,3',5-triiodothyroacetic acid has been researched along with Atrophy, Muscle in 4 studies
tiratricol : A monocarboxylic acid that is (4-hydroxy-3,5-diiodophenyl)acetic acid in which the phenolic hydroxy group has been replaced by a 4-hydroxy-3-iodophenoxy group. It is a thyroid hormone analogue that has been used in the treatment of thyroid hormone resistance syndrome.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
van Geest, FS | 1 |
Groeneweg, S | 1 |
van den Akker, ELT | 1 |
Bacos, I | 1 |
Barca, D | 1 |
van den Berg, SAA | 1 |
Bertini, E | 1 |
Brunner, D | 1 |
Brunetti-Pierri, N | 1 |
Cappa, M | 1 |
Cappuccio, G | 1 |
Chatterjee, K | 1 |
Chesover, AD | 1 |
Christian, P | 1 |
Coutant, R | 1 |
Craiu, D | 1 |
Crock, P | 1 |
Dewey, C | 1 |
Dica, A | 1 |
Dimitri, P | 1 |
Dubey, R | 1 |
Enderli, A | 1 |
Fairchild, J | 1 |
Gallichan, J | 1 |
Garibaldi, LR | 1 |
George, B | 1 |
Hackenberg, A | 1 |
Heinrich, B | 1 |
Huynh, T | 1 |
Kłosowska, A | 1 |
Lawson-Yuen, A | 1 |
Linder-Lucht, M | 1 |
Lyons, G | 1 |
Monti Lora, F | 1 |
Moran, C | 1 |
Müller, KE | 1 |
Paone, L | 1 |
Paul, PG | 1 |
Polak, M | 1 |
Porta, F | 1 |
Reinauer, C | 1 |
de Rijke, YB | 1 |
Seckold, R | 1 |
Menevşe, TS | 1 |
Simm, P | 1 |
Simon, A | 1 |
Spada, M | 1 |
Stoupa, A | 1 |
Szeifert, L | 1 |
Tonduti, D | 1 |
van Toor, H | 1 |
Turan, S | 1 |
Vanderniet, J | 1 |
de Waart, M | 1 |
van der Wal, R | 1 |
van der Walt, A | 1 |
van Wermeskerken, AM | 1 |
Wierzba, J | 1 |
Zibordi, F | 1 |
Zung, A | 1 |
Peeters, RP | 2 |
Visser, WE | 2 |
Bauer, AJ | 1 |
Kersseboom, S | 1 |
Horn, S | 1 |
Chen, J | 1 |
Friesema, EC | 1 |
Vaurs-Barrière, C | 1 |
Heuer, H | 1 |
Visser, TJ | 1 |
Krude, H | 1 |
Kühnen, P | 1 |
Biebermann, H | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Expanded Access Program for Tiratricol in Patients With Monocarboxylate Transporter 8 Deficiency Also Known as Allan-Herndon-Dudley Syndrome (AHDS)[NCT05911399] | 0 participants | Expanded Access | Available | ||||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
1 review available for 3,3',5-triiodothyroacetic acid and Atrophy, Muscle
Article | Year |
---|---|
Treatment of congenital thyroid dysfunction: Achievements and challenges.
Topics: Congenital Hypothyroidism; Hormone Replacement Therapy; Humans; Hydrolases; Infant, Newborn; Iodide | 2015 |
3 other studies available for 3,3',5-triiodothyroacetic acid and Atrophy, Muscle
Article | Year |
---|---|
Long-Term Efficacy of T3 Analogue Triac in Children and Adults With MCT8 Deficiency: A Real-Life Retrospective Cohort Study.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Infant; Male; M | 2022 |
Triac in the treatment of Allan-Herndon-Dudley syndrome.
Topics: Adult; Child; Humans; Mental Retardation, X-Linked; Muscle Hypotonia; Muscular Atrophy; Triiodothyro | 2019 |
In vitro and mouse studies supporting therapeutic utility of triiodothyroacetic acid in MCT8 deficiency.
Topics: Animals; Biological Transport; Cell Differentiation; Cell Line, Tumor; Cells, Cultured; Chlorocebus | 2014 |